Compliance Rate

Compliance Rate 41.94%
Compliant submissions 39
Incompliant submissions 54
Total trials 93

My Organizations' Clinical Trials

Showing 25 of 389 entries
View as:

Smoking Treatment of Prisoners

Phase: N/A Priority: Normal
NCT ID: NCT00110630 Org: User:
Start: 06/30/05 End: 09/30/07 Due: 09/30/08

Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1

Phase: N/A Priority: Normal
NCT ID: NCT00136825 Org: User:
Start: 03/31/03 End: 09/30/05 Due: 09/30/06

Imaging Biomarker for Addiction Treatment Outcome

Phase: N/A Priority: Normal
NCT ID: NCT03427424 Org: User:
Start: 07/10/19 End: 04/29/24 Due: 04/29/25

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1

Phase: N/A Priority: Normal
NCT ID: NCT00046813 Org: User:
Start: 08/31/01 End: 04/30/05 Due: 04/30/06

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00218231 Org: User:
Start: 01/31/04 End: 08/31/06 Due: 08/31/07

Effects of Propranolol on Responses to Drug-Related Imagery Scripts

Phase: N/A Priority: Normal
NCT ID: NCT00688805 Org: User:
Start: 12/12/07 End: 12/16/13 Due: 12/16/14

Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5

Phase: N/A Priority: Normal
NCT ID: NCT00015223 Org: User:
Start: 06/30/97 End: 08/31/99 Due: 08/31/00

Study to Reduce Intravenous Exposures (STRIVE)

Phase: N/A Priority: Normal
NCT ID: NCT00391482 Org: User:
Start: 06/30/02 End: 02/28/05 Due: 02/28/06

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03745339 Org: User:
Start: 06/07/19 End: 10/01/25 Due: 10/01/26

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

Phase: N/A Priority: Normal
NCT ID: NCT00089687 Org: User:
Start: 04/30/04 End: 05/31/05 Due: 05/31/06

Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients

Phase: N/A Priority: Normal
NCT ID: NCT00060814 Org: User:
Start: 06/30/02 End: 12/31/02 Due: 12/31/03

Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users

Phase: N/A Priority: Normal
NCT ID: NCT00004740 Org: User:
Start: 02/28/95 End: - Due: -

Behavioral Smoking Cessation Treatment - 1

Phase: N/A Priority: Normal
NCT ID: NCT00110825 Org: User:
Start: 02/29/04 End: 06/30/09 Due: 06/30/10

Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates

Phase: N/A Priority: Normal
NCT ID: NCT00865332 Org: User:
Start: 12/12/07 End: 12/21/10 Due: 12/21/11

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Phase: N/A Priority: Normal
NCT ID: NCT00089440 Org: User:
Start: 06/30/04 End: 03/31/05 Due: 03/31/06

Bupropion as an Adjunct to the Nicotine Patch Plus CBT

Phase: N/A Priority: Normal
NCT ID: NCT00142831 Org: User:
Start: 04/30/99 End: 08/31/06 Due: 08/31/07

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Phase: N/A Priority: Normal
NCT ID: NCT00218101 Org: User:
Start: 05/31/04 End: 03/31/05 Due: 03/31/06

Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients

Phase: N/A Priority: Normal
NCT ID: NCT01229163 Org: User:
Start: 10/03/10 End: 04/19/12 Due: 04/19/13

Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation

Phase: N/A Priority: Normal
NCT ID: NCT01037608 Org: User:
Start: 05/08/07 End: 12/12/11 Due: 12/12/12

Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality

Phase: N/A Priority: Normal
NCT ID: NCT01212081 Org: User:
Start: 09/26/10 End: 11/26/12 Due: 11/26/13

A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches

Phase: N/A Priority: Normal
NCT ID: NCT00134927 Org: User:
Start: 09/30/05 End: 11/30/06 Due: 11/30/07

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use

Phase: N/A Priority: Normal
NCT ID: NCT00218244 Org: User:
Start: 08/31/01 End: 11/30/04 Due: 11/30/05

Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin

Phase: N/A Priority: Normal
NCT ID: NCT02393599 Org: User:
Start: 05/31/15 End: 09/30/15 Due: 09/30/16

Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use

Phase: N/A Priority: Normal
NCT ID: NCT00218270 Org: User:
Start: 12/31/02 End: 05/31/05 Due: 05/31/06

Interactions Between Intravenous Cocaine and Acetazolamide or Quinine

Phase: N/A Priority: Normal
NCT ID: NCT01851473 Org: User:
Start: 10/24/12 End: 10/07/15 Due: 10/07/16